Skip to main content

Table 2 Distribution of persistenta and clearedb high-risk (hr) human papillomavirus (HPV) infections in 71 included WLWH

From: Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark – the SHADE

  HrHPV infections, n(% of total number of WLWH) (n = 112) HrHPV persistence, n(%) HrHPV clearance, n(%)
hrHPV16 12 (10.7) 4 (33.3) 8 (66.7)
hrHPV18 5 (4.4) 0 (0) 5 (100.0)
hrHPV31 10 (8.9) 4 (40.0) 6 (60.0)
hrHPV33 7 (6.3) 3 (42.9) 4 (57.1)
hrHPV35 13 (11.6) 5 (38.5) 8 (61.5)
hrHPV39 4 (3.6) 0 (0) 4 (100.0)
hrHPV45 3 (2.7) 1 (33.3) 2 (66.7)
hrHPV51 13 (11.6) 4 (30.8) 9 (69.2)
hrHPV52 14 (12.5) 11 (78.6) 3 (21.4)
hrHPV56 5 (4.4) 1 (20.0) 4 (80.0)
hrHPV58 20 (17.9) 5 (25.0) 15 (75.0)
hrHPV59 0 (0) 0 (0) 0 (0)
hrHPV68 6 (5.4) 0 (0) 6 (100.0)
  1. WLWH = women living with HIV
  2. aPersistent = Type-specific persistence was defined as positivity of the same hrHPV type in two separate cervical samples having been taken at least 1 year and at most 2 years after the date the patient was first hrHPV positive, bCleared = having one or more negative results after an hrHPV positive sample